Abstract
Through 2012, growth in the US infusion pump market - comprising insulin,
volumetric, disposable ambulatory, enteral, electronic ambulatory, and syringe
pumps - will be driven by product innovation and the clinical advantages of
infusion pumps relative to alternative modalities.
Driving growth within multiple infusion pump segments will be the integration
of extensive medication error prevention software used in conjunction with
infusion pumps, and products with wireless connectivity to hospital
information technology (IT) systems.
View Cart
